Tushar Pandey: Hounoured to Be Part of Hematocon 2025
Tushar Pandey, Editorial Board Member at Journal of Cancer Chemotherapy, shared on LinkedIn:
”HONOURED TO BE PART OF HEMATOCON 2025
Grateful for the opportunity to represent HALDWANI, UTTARAKHAND and the RAGHAV INSTITUTE OF HEMATOLOGY, HEMATO-ONCOLOGY and BONE MARROW TRANSPLANT (RIHOB) as FACULTY at the National Hematology Conference — Hematocon 2025.
Participated in a deeply insightful session on “INFECTIONS IN BONE MARROW TRANSPLANT AND NEUTROPENIC SETTINGS AND THEIR MANAGEMENT,” an area that remains vital to improving outcomes and safety in hematology and transplant care.
It was a privilege to share thoughts and exchange ideas with distinguished HEMATOLOGISTS — DR. Faheema Hasan , DR. ADITYA JANDIAL, DR. POORVI KAPOOR, AND DR. SAYAN ROY.
The discussion brought forward valuable perspectives on managing complex infections in immunocompromised patients.
Looking forward to continuing our collective efforts to strengthen hematology and transplant services across UTTARAKHAND AND NORTH INDIA.
Committed to advancing excellence in Hematology, Oncology and BMT care.”
Stay updated with Hemostasis Today.
-
Dec 15, 2025, 15:58Khaled Musallam Applauds Hatoon Ezzat’s Leadership and Healthcare Advances in Saudi Arabia
-
Dec 15, 2025, 12:46Deborah Ebert Long on Hemophilia Care: Progress, Possibility, and the Power of Listening
-
Dec 15, 2025, 12:34Nathan Connell on Conversion from Eptacog Alfa to Beta
-
Dec 15, 2025, 12:17Danny Hsu on Interdisciplinary Toolkit for Gynecologic Bleeding on Anticoagulation
-
Dec 15, 2025, 12:08Ted Roh: A Historic Milestone for Indonesia’s Health Innovation
-
Dec 15, 2025, 11:28Wolfgang Miesbach Shares Insights from Davide Matino’s Presentation on Marstacimab at ASH25
-
Dec 15, 2025, 11:12Tushar Pandey Awarded for His Enourmous Contribution to Hematology
-
Dec 15, 2025, 11:07DISTRO: Vidya Rajbhoj on AI and Digital Technology to Improve Stroke Rehabilitation
-
Dec 15, 2025, 11:00Ischemic Stroke, AF and Atherosclerotis: Amira Khater on Sufficiency of Anticoagulant Monotherapy